Novel plasma peptide markers involved in the pathology of CKD identified using mass spectrometric approach

Chronic kidney disease (CKD) may progress to end-stage renal disease (ESRD) at different pace. Early markers of disease progression could facilitate and improve patient management. However, conventional blood and urine chemistry have proven unable to predict the progression of disease at early stage...

Full description

Saved in:
Bibliographic Details
Main Authors: Gajjala, Prathibha Reddy (Author) , Sáez Rodríguez, Julio (Author)
Format: Article (Journal)
Language:English
Published: 5 August 2019
In: Journal of molecular medicine
Year: 2019, Volume: 97, Issue: 10, Pages: 1451-1463
ISSN:1432-1440
DOI:10.1007/s00109-019-01823-8
Online Access:Verlag, Volltext: https://doi.org/10.1007/s00109-019-01823-8
Get full text
Author Notes:Prathibha R. Gajjala, Heike Bruck, Heidi Noels, Georg Heinze, Francesco Ceccarelli, Andreas Kribben, Julio Saez-Rodriguez, Nikolaus Marx, Walter Zidek, Joachim Jankowski, Vera Jankowski

MARC

LEADER 00000caa a2200000 c 4500
001 1679039369
003 DE-627
005 20230427135320.0
007 cr uuu---uuuuu
008 191017s2019 xx |||||o 00| ||eng c
024 7 |a 10.1007/s00109-019-01823-8  |2 doi 
035 |a (DE-627)1679039369 
035 |a (DE-599)KXP1679039369 
035 |a (OCoLC)1341248158 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Gajjala, Prathibha Reddy  |e VerfasserIn  |0 (DE-588)1166605949  |0 (DE-627)1030503990  |0 (DE-576)510816428  |4 aut 
245 1 0 |a Novel plasma peptide markers involved in the pathology of CKD identified using mass spectrometric approach  |c Prathibha R. Gajjala, Heike Bruck, Heidi Noels, Georg Heinze, Francesco Ceccarelli, Andreas Kribben, Julio Saez-Rodriguez, Nikolaus Marx, Walter Zidek, Joachim Jankowski, Vera Jankowski 
264 1 |c 5 August 2019 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 17.10.2019 
520 |a Chronic kidney disease (CKD) may progress to end-stage renal disease (ESRD) at different pace. Early markers of disease progression could facilitate and improve patient management. However, conventional blood and urine chemistry have proven unable to predict the progression of disease at early stages. Therefore, we performed untargeted plasma peptidome analysis to select the peptides involved in progression, which are suitable for long prospective studies in future. The study consists of non-CKD (n = 66) and CKD (n = 106) patients with different stages. We performed plasma peptidomics on these subjects using chromatography and mass spectrometric approaches. Initially, we performed LC-ESI-MS and applied least absolute shrinkage and selection operator logistic regressions to select the peptides that are differentially expressed and we generated a peptidomic score for each subject. Later, we identified and sequenced the peptides with MALDI-MS/MS and also performed univariate and multivariate analyses with the clinical variables and peptidomic score to reveal their association with progression of renal disease. A logistic regression model selected 14 substances showing different concentrations according to renal function, of which seven substances were most likely occur in CKD patients. The peptidomic model had a global P value of < 0.01 with R2 of 0.466, and the area under the curve was 0.87 (95% CI, 0.8149-0.9186; P < 0.0001). The predicted score was significantly higher in CKD than in non-CKD patients (2.539 ± 0.2637 vs − 0.9382 ± 0.1691). The model was also able to predict stages of CKD: the Spearman correlation coefficient of the linear predictor with CKD stages was 0.83 with concordance indices of 0.899 (95% CI 0.863-0.927). In univariate analysis, the most consistent association of peptidomic score in CKD patients was with C-reactive protein, sodium level, and uric acid, which are unanticipated substances. Peptidomic analysis enabled to list some unanticipated substances that have not been extensively studied in the context of CKD but were associated with CKD progression, thus revealing interesting candidate markers or mediators of CKD of potential use in CKD progression management.Key messages• Conventional blood and urine chemistry have proven unable to predict the progression of disease at early stages of chronic kidney disease (CKD).• We performed untargeted plasma peptidome analysis to select the peptides involved in progression.• A logistic regression model selected 14 substances showing different concentrations according to renal function.• These peptides are unanticipated substances that have not been extensively studied in the context of CKD but were associated with CKD progression, thus revealing markers or mediators of CKD of potential use in CKD progression management. 
650 4 |a Chronic kidney disease 
650 4 |a Disease progression 
650 4 |a End-stage renal disease 
650 4 |a peptidomics 
650 4 |a proteomics 
650 4 |a Systems medicine 
700 1 |a Sáez Rodríguez, Julio  |d 1978-  |e VerfasserIn  |0 (DE-588)133764362  |0 (DE-627)555766632  |0 (DE-576)300083114  |4 aut 
773 0 8 |i Enthalten in  |t Journal of molecular medicine  |d Berlin : Springer, 1995  |g 97(2019), 10, Seite 1451-1463  |h Online-Ressource  |w (DE-627)254630804  |w (DE-600)1462132-0  |w (DE-576)079420028  |x 1432-1440  |7 nnas  |a Novel plasma peptide markers involved in the pathology of CKD identified using mass spectrometric approach 
773 1 8 |g volume:97  |g year:2019  |g number:10  |g pages:1451-1463  |g extent:13  |a Novel plasma peptide markers involved in the pathology of CKD identified using mass spectrometric approach 
856 4 0 |u https://doi.org/10.1007/s00109-019-01823-8  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20191017 
993 |a Article 
994 |a 2019 
998 |g 133764362  |a Sáez Rodríguez, Julio  |m 133764362:Sáez Rodríguez, Julio  |d 910000  |d 912900  |d 700000  |d 716000  |e 910000PS133764362  |e 912900PS133764362  |e 700000PS133764362  |e 716000PS133764362  |k 0/910000/  |k 1/910000/912900/  |k 0/700000/  |k 1/700000/716000/  |p 7 
999 |a KXP-PPN1679039369  |e 3523421136 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"origin":[{"publisherPlace":"Berlin ; Heidelberg ; New York, NY","dateIssuedDisp":"1995-","dateIssuedKey":"1995","publisher":"Springer"}],"physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["Volume 73, issue 1 (January 1995)-"],"recId":"254630804","id":{"zdb":["1462132-0"],"issn":["1432-1440"],"eki":["254630804"]},"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Novel plasma peptide markers involved in the pathology of CKD identified using mass spectrometric approachJournal of molecular medicine","language":["eng"],"part":{"year":"2019","pages":"1451-1463","extent":"13","text":"97(2019), 10, Seite 1451-1463","volume":"97","issue":"10"},"title":[{"title_sort":"Journal of molecular medicine","title":"Journal of molecular medicine"}],"note":["Gesehen am 14.03.25"]}],"note":["Gesehen am 17.10.2019"],"language":["eng"],"title":[{"title":"Novel plasma peptide markers involved in the pathology of CKD identified using mass spectrometric approach","title_sort":"Novel plasma peptide markers involved in the pathology of CKD identified using mass spectrometric approach"}],"person":[{"given":"Prathibha Reddy","role":"aut","family":"Gajjala","display":"Gajjala, Prathibha Reddy"},{"display":"Sáez Rodríguez, Julio","family":"Sáez Rodríguez","role":"aut","given":"Julio"}],"id":{"doi":["10.1007/s00109-019-01823-8"],"eki":["1679039369"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"name":{"displayForm":["Prathibha R. Gajjala, Heike Bruck, Heidi Noels, Georg Heinze, Francesco Ceccarelli, Andreas Kribben, Julio Saez-Rodriguez, Nikolaus Marx, Walter Zidek, Joachim Jankowski, Vera Jankowski"]},"physDesc":[{"extent":"13 S."}],"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"5 August 2019"}],"recId":"1679039369"} 
SRT |a GAJJALAPRANOVELPLASM5201